Genomic imprinting of a human apoptosis gene homologue, TSSC3.

Genomic imprinting is an epigenetic modification of the gamete or zygote leading to parental origin-specific gene expression in somatic cells of the offspring. We have previously identified a cluster of imprinted genes on human chromosome 11p15.5, a region involved in Beckwith-Wiedemann syndrome, Wilms' tumor, and ovarian, breast, and lung cancer. Here we show that TSSC3, which is homologous to the mouse apoptosis gene TDAG51 and maps to this region, is imprinted and expressed from the maternal allele in normal development. This result is important for three reasons: (a) TSSC3 is the first apoptosis-related gene in any species found to be imprinted; (b) it is located within the tumor suppressor region of 11p15; and (c) it lies within 15 kb of the nonimprinted gene hNAP2, thus defining a small boundary interval between imprinted and nonimprinted genes on 11p.

[1]  A. Feinberg,et al.  A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes. , 1997, Genomics.

[2]  G. Evan,et al.  Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. , 1997, Science.

[3]  B. Tycko,et al.  The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. , 1997, Human molecular genetics.

[4]  B. Tycko,et al.  Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. , 1997, American journal of human genetics.

[5]  A. Feinberg,et al.  Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor. , 1996, Cancer research.

[6]  A. Feinberg,et al.  A novel human homologue of yeast nucleosome assembly protein, 65 kb centromeric to the p57KIP2 gene, is biallelically expressed in fetal and adult tissues. , 1996, Human molecular genetics.

[7]  E. Russell,et al.  Fas expression and function in normal and malignant breast cell lines. , 1996, Cancer research.

[8]  C. Park,et al.  A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. , 1996, Immunity.

[9]  A. Zelenetz,et al.  A novel L23-related gene 40 kb downstream of the imprinted H19 gene is biallelically expressed in mid-fetal and adult human tissues. , 1995, Human molecular genetics.

[10]  G. Evan,et al.  c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.

[11]  A. Feinberg.  A developmental context for multiple genetic alterations in Wilms’ tumor , 1994, Journal of Cell Science.

[12]  A. Feinberg,et al.  Parental Imprinting of Human Chromosome Region 11p15.3-pter Involved in the Beckwith-Wiedemann Syndrome and Various Human Neoplasia , 1994, European journal of human genetics : EJHG.

[13]  Benjamin Tycko,et al.  Tumour-suppressor activity of H19 RNA , 1993, Nature.

[14]  R. Weksberg,et al.  Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome , 1993, Nature genetics.

[15]  A. Feinberg,et al.  Relaxation of imprinted genes in human cancer , 1993, Nature.

[16]  A. Feinberg,et al.  Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11 , 1993, Science.

[17]  M. Eccles,et al.  Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour , 1993, Nature.

[18]  Chris Graham,et al.  Genomic imprinting and the strange case of the insulin-like growth factor II receptor , 1991, Cell.

[19]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.